Inventor profile of:

Patrick Gosselin

City:

Laval

Country:

Canada

Published Applications:

24

Last publication date:

2024-10-03

Top Assignees for applications by Patrick Gosselin

The entities that hold a legal rights for patent applications filed by inventor Gosselin Patrick:

Recent patent applications by Gosselin Patrick

Patrick Gosselin from Laval, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-10-03
US20240325313A1
Human necessities

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HELICOBACTER PYLORI

#2 | 2023-06-08
US20230174493A1
Chemistry; metallurgy

Solid Dispersions of Amorphous 3,4-Diphenyl-4,5-Dihydro-1H-Pyrazole Derivatives, Compositions Comprising them and Uses Thereof as Cannabinoid CB1 Receptor Inhibitors

#3 | 2022-03-03
US20220062188A1
Human necessities

All-in-one fixed-dose combination for treating infection

#4 | 2020-07-02
US20200206253A1
Human necessities

Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine

#5 | 2020-01-30
US20200030352A1
Human necessities

Method for treating crohn's disease using triple antimicrobial all-in-one formulation

#6 | 2019-11-07
US20190336451A1
Human necessities

Rifabutin-based compositions and methods for treating infection

#7 | 2019-06-13
US20190175512A1
Human necessities

Methods for treating helicobacter pylori infection

#8 | 2019-03-07
US20190070138A1
Human necessities

Solid dosage forms of vigabatrin

#9 | 2019-02-28
US20190060343A1
Human necessities

Methods of treating a bacterial infection using a fixed-dose pharmaceutical composition comprising three antibiotics

#10 | 2018-05-10
US20180125872A1
Human necessities

Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine

#11 | 2018-04-26
US20180110734A1
Human necessities

Pharmaceutical compositions comprising lonafarnib and ritonavir

#12 | 2018-02-01
US20180028452A1
Human necessities

ANTIEMETIC EXTENDED RELEASE SOLID DOSAGE FORMS

#13 | 2017-08-17
US20170232028A1
Human necessities

Pharmaceutical compositions comprising three antibiotics

#14 | 2017-07-06
US20170189341A1
Human necessities

Pharmaceutical compositions for the treatment of

#15 | 2016-08-18
US20160235681A1
Human necessities

Pharmaceutical compositions for the treatment of

#16 | 2016-08-11
US20160228464A1
Human necessities

COMPOSITIONS COMPRISING RIFABUTIN, CLARITHROMYCIN, AND CLOFAZIMINE AND USES THEREOF

#17 | 2016-06-23
US20160175356A1
Human necessities

Formulations of calcium and phosphate for oral inflammation

#18 | 2015-02-12
US20150044283A1
Human necessities

Pharmaceutical compositions for the treatment of

#19 | 2014-10-23
US20140315841A1
Human necessities

Compositions comprising rifabutin, clarithromycin, and clofazimine and uses thereof

#20 | 2014-09-18
US20140271851A1
Human necessities

ANTIEMETIC EXTENDED RELEASE SOLID DOSAGE FORMS

#21 | 2014-08-28
US20140243279A1
Human necessities

Methods and compositions comprising rifabutin, clarithromycin, and clofazimine

#22 | 2014-08-14
US20140227353A1
Human necessities

Pharmaceutical compositions for the treatment of

#23 | 2013-09-12
US20130237488A1
Human necessities

Methods and compositions for treating inflammatory bowel disease

#24 | 2011-03-10
US20110059136A1
Human necessities

Methods and compositions for treating inflammatory bowel disease

InventorID:

434626 ⎘